A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 132.54
GOOG 540.11
MSFT 46.90
FB 80.54
BAC 16.75

Recently Added

SLIO 0.00
SLNN 0.00
EOG 90.26
LOCK 15.24
MZOR 13.01

Gaining Speed

SLIO 0.00
SLNN 0.00
TLFX 0.00
FB 80.54
AAPL 132.54

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More




Get Alerted When News Hits On This Stock - FREE!